World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
31018
World Ranking
16453
National Ranking
186

Tak Mao Chan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tak Mao Chan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 522 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tak Mao Chan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tak Mao Chan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tak Mao Chan is affiliated with the University of Hong Kong in China and specializes primarily in Medicine with a substantial focus on nephrology and related subfields.

Their research spans several interconnected areas, including Nephrology, Rheumatology, Immunology, Hematology, and Hepatology. The primary topics covered in their work include:

  • Systemic Lupus Erythematosus Research
  • Renal Diseases and Glomerulopathies
  • Dialysis and Renal Disease Management
  • Liver Diseases and Immunity
  • Platelet Disorders and Treatments
  • Erythropoietin and Anemia Treatment
  • Chronic Kidney Disease and Diabetes

Tak Mao Chan's publication record shows extensive involvement in nephrology and related biomedical research, with frequent contributions to the following venues:

  • Journal of the American Society of Nephrology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Kidney International Reports
  • Nephrology
  • Frontiers in Immunology

Recent significant papers featuring Tak Mao Chan's research interests include:

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS, 2024, Kidney International
  • Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system, 2021, Cell
  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy, 2022, JAMA

The scientist frequently collaborates with other researchers, notably:

  • Susan Yung
  • Desmond Y. H. Yap
  • Vivekanand Jha
  • Sydney Tang
  • Zhihong Liu

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

    T M Chan;F K Li;C S Tang;R W Wong

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

    Tak Mao Chan;Fu Keung Li;Colin S.O. Tang;Raymond W.S. Wong

  • Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

    Jay Kay;Wing Hing Chow;Tak Mao Chan;Sing Kai Lo

  • Long-Term Study of Mycophenolate Mofetil as Continuous Induction and Maintenance Treatment for Diffuse Proliferative Lupus Nephritis

    Tak-Mao Chan;Kai-Chung Tse;Colin Siu-On Tang;Mo-Yin Mok

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.

    Wanling Yang;Nan Shen;Dong-Qing Ye;Qiji Liu;Qiji Liu

  • Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

    Jicheng Lv;Jicheng Lv;Hong Zhang;Muh Geot Wong;Meg J. Jardine

  • Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo

    Sydney Tang;Joseph C.K. Leung;Katsushige Abe;Kwok Wah Chan

  • Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study.

    Wai-Kei Lo;Yiu-Wing Ho;Chun-Sang Li;Kin-Shing Wong

  • Survival analysis and causes of mortality in patients with lupus nephritis

    Desmond Y.H. Yap;Colin S.O. Tang;Maggie K.M. Ma;Man Fai Lam

  • A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

    Brad H. Rovin;Neil Solomons;William F. Pendergraft;Mary Anne Dooley

  • Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Hiddo J L Heerspink;Tom Greene;Hocine Tighiouart;Hocine Tighiouart;Ron T Gansevoort

  • Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.

    Man Lung Yeung;Jade Lee Lee Teng;Lilong Jia;Chaoyu Zhang

  • Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays

    Tak Mao Chan;Anna Suk Fong Lok;Ignatius Kum Po Cheng;Rachel Tzun Chan

  • Recurrent glomerulonephritis after kidney transplantation

    B. Y. Choy;T. M. Chan;K. N. Lai

  • Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians

    Wanling Yang;Huayang Tang;Yan Zhang;Xianfa Tang

  • Preemptive lamivudine therapy based on HBV DNA level in HBsAg‐positive kidney allograft recipients

    Tak Mao Chan;Guo Xiang Fang;Colin S. O. Tang;Ignatius K. P. Cheng

  • Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.

    T M Chan;K C Tse;C S O Tang;K N Lai

Frequent Co-Authors

Chak Sing Lau
Chak Sing Lau University of Hong Kong
Yu-Lung Lau
Yu-Lung Lau University of Hong Kong
Ching-Lung Lai
Ching-Lung Lai University of Hong Kong
Pak C. Sham
Pak C. Sham University of Hong Kong
Joseph Leung
Joseph Leung University of California, Davis
Qianjin Lu
Qianjin Lu Central South University
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
Irene Oi-Lin Ng
Irene Oi-Lin Ng University of Hong Kong
Stacey S. Cherny
Stacey S. Cherny Tel Aviv University
Dimitrios T. Boumpas
Dimitrios T. Boumpas National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open new pathways for those interested in health sciences and related careers. For registered nurses seeking advancement, what is the cheapest rn to bsn program online helps identify budget-friendly ways to earn a BSN, expanding both knowledge and job prospects.

Individuals without a nursing background may consider direct entry nurse practitioner programs for non-nurses online. These fast-track options allow career changers to enter advanced practice nursing roles sooner.

Acceptance rates can be a concern for prospective students. For those seeking less competitive entry, nursing schools with high acceptance rates provide greater opportunity for admission into nursing programs across the country.

Not all healthcare careers require clinical training. Those interested in administrative roles might explore medical billing and coding. Finding schools that offer medical billing and coding financial aid can make this career path more affordable and accessible.

Best Scientists Citing Tak Mao Chan

Trending Scientists

Recently Published Articles